Rabinovich and colleagues identified that prostate cancer shows a unique galectin expression profile during cancer progression, and showed that galectin-1 is uniquely expressed at high levels in advanced prostate cancer [104]. This evidence concerns the gene LGALS1 and prostate carcinoma.